|
|
||||||||
1 Nuclear Magnetic Resonance Center and 2 Positron-Emission Tomography Laboratory, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129; and 3 Department of Molecular and Cellular Physiology, Pennsylvania State University Medical School, Hershey, Pennsylvania 17033
| |
ABSTRACT |
|---|
|
|
|---|
To test how
-ketoglutarate dehydrogenase (
-KGDH) activity influences the
balance between oxidative flux and transmitochondrial metabolite
exchange, we monitored these rates in isolated mitochondria and in
perfused rabbit hearts at an altered kinetics
(Km) of
-KGDH for
-ketoglutarate (
-KG). In isolated mitochondria,
relative Km
dropped from 0.23 mM at pH = 7.2 to 0.10 mM at pH 6.8 (P < 0.05), and
-KG
efflux decreased from 126 to 95 nmol · min
1 · mg
1.
In intact hearts,
Km was reduced
with low intracellular pH, while matching control workload and
respiratory rate with increased Ca2+
(pHi = 7.20, perfusate
CaCl2 = 1.5 mM;
pHi = 6.89, perfusate CaCl2 = 3 ± 1 mM). Sequential
13C nuclear magnetic resonance
spectra from hearts oxidizing
[2-13C]acetate
provided tricarboxylic acid cycle flux and the exchange rate between
-KG and cytosolic glutamate
(F1).
Tricarboxylic acid cycle flux was 10 µmol · min
1 · g
1
in both groups, but
F1 fell from a
control of 9.3 ± 0.6 to 2.8 ± 0.4 µmol · min
1 · g
1
at low Km. The
results indicate that increased activity of
-KGDH occurs at the
expense of
-KG efflux during support of normal workloads.
metabolic regulation; tricarboxylic acid cycle; myocardium; nuclear magnetic resonance
| |
INTRODUCTION |
|---|
|
|
|---|
IN THIS STUDY, we examined the potential for metabolic
coordination between the mitochondrial dehydrogenase reactions and metabolite influx and efflux across the mitochondrial membrane in
intact functioning hearts. In particular, this work focused on the
coordination between the rate-limiting dehydrogenase of the first span
of the tricarboxylic acid (TCA) cycle,
-ketoglutarate dehydrogenase
(
-KGDH), and metabolite transport via the
-ketoglutarate-malate exchanger on the mitochondrial membrane. Although already established in the isolated mitochondrial preparation (12, 31), the role of the
mitochondrial dehydrogenases in coordinating TCA cycle flux
(VTCA) and the
metabolite exchange rates between the cytosol and mitochondria has yet
to be demonstrated in the intact beating heart. Thus a combination of
flux measurements from the dynamic mode
13C nuclear magnetic spectroscopy
(NMR) of the intact heart and radiotracer analysis of isolated heart
mitochondria provides new insight into coordinating intermediary
metabolism between the cytosol and mitochondria to support cardiac
function.
Two exchange proteins of the mitochondrial membrane provide one
mechanism by which cytosolic metabolites exchange with mitochondrial metabolites: the reversible
-ketoglutarate-malate exchanger and the
unidirectional glutamate-aspartate exchanger. These two transporters may function separately, but when operating in tandem, they form the
malate-aspartate shuttle (10). The exchange of metabolites between
mitochondria and cytosol may then be coordinated with mitochondrial TCA
cycle activity at the level of the enzyme
-ketoglutarate dehydrogenase (
-KGDH).
-KGDH oxidizes
-ketoglutarate to form succinyl CoA within the TCA cycle. In this manner,
-KGDH regulates VTCA through the
second span of the cycle (23) and competes with the mitochondrial
membrane transporter for
-ketoglutarate (11). The subsequent efflux
and transamination of
-ketoglutarate, via the glutamate-oxaloacetate
transaminase (GOT), produces cytosolic glutamate. This balance between
VTCA and
metabolite exchange rates can be evaluated by analysis of dynamic
13C NMR spectra of carbon isotope
enrichment of glutamate in the intact heart (33-35). In the
isolated mitochondria, the unidirectional influx or efflux of
-ketoglutarate and malate across the mitochondrial membrane can also
be measured with ambiguity for comparison to the isotope kinetics in
the intact heart. Such a combined information can be interpreted to
define changes in the activity of the enzymes coordinating these
processes.
We have previously shown that the rate of the transaminase GOT is much
too fast to be a rate-determining component of the observed
interconversion rate between
-ketoglutarate and glutamate in intact
hearts by directly measuring the activities of the mitochondrial and
cytosolic isozymes of GOT in rabbit myocardium (34). Instead, the much
slower rate of interconversion can be attributed not to the
transaminase but rather to the transport processes that bring
-ketoglutarate out of the mitochondria for transamination with the
large cytosolic glutamate pool.
Subsequent work from our laboratory has determined that 13C NMR methods are sensitive to both VTCA and rates of metabolite transport between the mitochondria and cytosol in intact functioning hearts (33-35). Unlike more traditional assay and isolation techniques, 13C NMR spectroscopy provides an approach to characterize the activity of the TCA cycle, exchange rates, and potentially the kinetics of specific enzymes in the intact tissue under normal, diseased, or altered function.
In this study, alteration of the kinetics
(Km) of the key
rate-limiting enzyme of the TCA cycle,
-KGDH, was studied in both intact hearts and isolated mitochondria. As the substrate concentration at which the reaction for the given enzyme reaches half-maximal velocity, Km served as a kinetic index of the
substrate-enzyme affinity. The affinity of
-KGDH for the substrate
-ketoglutarate was increased (i.e., a reduction in
Km) by reducing
intramitochondrial pH and increasing calcium content. Combined studies
of
-ketoglutarate oxidation and efflux from isolated rabbit heart
mitochondria and NMR assessment of stable isotope enrichment of
glutamate provided a unique opportunity to study the balance between
-ketoglutarate transport and oxidation as a function of the affinity
of the
-KGDH for its substrate. The analysis presented here
indicates that changes in the kinetic parameters of
-ketoglutarate
oxidation rates mediate changes in
-ketoglutarate efflux from
mitochondria at constant
VTCA. For the
first time, we establish the influence of pH and
Ca2+ on the cardiac
-KGDH in
the intact heart, while demonstrating the role this dehydrogenase plays
in coordinating cytosolic metabolism with that oxidative energy
production pathways.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Isolated Heart Model
Isolated hearts were prepared as previously described in a number of earlier studies (13, 18, 32, 34, 35). Dutch Belted rabbits (500 g) were injected with heparin (20 U) and anesthetized with ketamine (500 U) and Telozol (200 U). Hearts were excised from the rabbits and retrograde perfused via aortic cannulation with a modified, phosphate-free Krebs-Henseleit buffer solution containing (in mM) 116 NaCl, 4 KCl, 1.5 CaCl2, 1.2 MgSO4, 1.2 NaHPO4, 25 NaHCO3, and 5 glucose and oxygenated with 95% O2-5% CO2. The hydrostatic perfusion column was 100 cm, and temperature of the buffer at the myocardium was maintained at 37°C. A latex balloon containing water was inserted into the left ventricle. The balloon was connected to a pressure transducer to enable the monitoring of left ventricular developed pressure (LVDP) and heart rate (HR) throughout each experiment. The end-diastolic pressure of the heart was set at 5-10 mmHg by adjusting the volume of the balloon. Myocardial oxygen consumption (M
O2)
was calculated from the difference in
O2 content of perfusion medium in
the supply line, and coronary effluent was collected from the pulmonary
artery (21).
Perfusate pH was reduced from 7.2 to 6.6 by decreasing the buffer
content of bicarbonate to 6 mM. As previously reported, there is a
simultaneous reduction in LVDP and HR at low pH (32). To maintain
normal VTCA rates
at this low pH, supplemental CaCl2 was added to the perfusate to normalize the rate-pressure product (RPP)
and match control levels of
M
O2 (32). With the
metabolic demands of the heart normalized, we then utilized
13C NMR spectroscopy to monitor
VTCA and the
interconversion between
-ketoglutarate and glutamate in response to
reduced Km of
-KGDH for
-ketoglutarate.
Experimental Protocol
All hearts were perfused with the modified Krebs-Henseleit buffer containing 5 mM unlabeled glucose. Coronary effluent was discarded, and the hearts were given 10 min to stabilize rate-pressure product (RPP = HR × LVDP) before the buffer substrate was switched from the glucose to 2.5 mM unenriched acetate. The buffer substrate was then switched from unlabeled acetate to a recirculated reservoir of 2.5 mM enriched [2-13C]acetate (Isotec, Miamisburg, OH) for 40 min to ensure steady-state isotopic enrichment at the end point of the protocol (13, 18). Subsequent 31P and 13C NMR spectra were acquired from two experimental groups: a control group (buffer pH = 7.3 ± 0.1, n = 7) and a group with increased affinity of
-KGDH for
-ketoglutarate (i.e., a reduction in
Km) by
perfusing at low pH and increased buffer
CaCl2 to normalize cardiac
function and respiratory rates as described above (buffer pH = 6.6 ± 0.1, CaCl2 = 3.0 ± 1.0 mM; n = 7). The hearts were then
removed from the magnet, freeze-clamped, and prepared for biochemical
assays and high-resolution 13C NMR
analysis.
NMR Measurements
For NMR analysis, perfused hearts were positioned in a 20-mm broad-band probe and placed in a 9.4-T/89-mm vertical-bore superconducting NMR magnet. The magnet was interfaced to a Bruker MSL 400 system for data acquisition. Magnetic field homogeneity was optimized by first shimming all hearts to a proton linewidth of 15-30 Hz. After 10 min of shimming, we acquired a 31P spectrum of heart to establish heart viability, high-energy phosphate content, and intracellular pH. 31P NMR spectra were acquired in 128 scans using a 161-MHz, 45° excitation pulse, a 1.8-s repetition time, 35 parts/min sweep width, and 8 K data set. Postprocessing of the summed free induction decay (FID) NMR data included 20-Hz line broadening, Fourier transformation, and phase correction. Peak assignments were made with reference to the well-established resonance signals of phosphocreatine and
-,
-, and
-ATP. Intracellular pH was calculated based on
the chemical shift of the inorganic phosphate signal as described previously (20).
Carbon spectra were acquired at 100 MHz with a bilevel broad-band decoupling scheme (14). Carbon spins were nutated with a 45° excitation pulse, 64-scans per 2.5-min spectrum, 10,000-Hz sweep width, and 8 K data set. Proton excitation at 400 MHz, 0.5 W during the interpulse delay, and 7.0 W for 17 µs was applied to irradiate carbon-proton coupling and produce nuclear Overhauser enhancement of carbon signal. Postprocessing of the summed FID values NMR data included 20-Hz line broadening, Fourier transformation, and phase correction. Natural abundant 13C NMR signal was subtracted from subsequent 13C-enriched spectra. Resonance signals were identified by chemical shift values (parts/min) referenced to dioxane at 67.4 parts/min. The signal intensity of each resonance was determined by curve fitting the peak to a Lorentzian curve and integrating the area of the fit (NMR1 software, Tripos, St. Louis, MO).
Tissue Chemistry
After perfusion experiments, hearts were freeze-clamped, cooled in liquid nitrogen, and then ground to a powder form. One gram of tissue was added to 2 g of 6% perchloric acid. After 10 min, the sample was centrifuged, the pellet was discarded, and the supernatant pH was adjusted to 7.2. An aliquot of this extract was used for biochemical analysis. Glutamate,
-ketoglutarate, citrate, and aspartate
concentrations were determined from spectrophotometric and fluorometric
techniques (1, 30). The remainder of the extract was lyophilized and
resuspended in D2O for
high-resolution NMR analysis.
The pH response of GOT activity from the cytosol of rabbit hearts was determined using methods to measure maximal reaction velocity of the isolated isoenzymes as previously described (15, 34). Separated cytosolic fractions of homogenized rabbit myocardium were tested for GOT activity, and the Km for each substrate was determined under two different pH conditions, 7.2 and 6.8.
High-Resolution 13C NMR
13C NMR high-resolution spectra of heart extracts were acquired with a 5-mm 13C probe and 9.4-T Bruker spectrometer system. Carbons were given a 45° excitation pulse, at a 1.8-s repetition, with a 100 parts/min sweep width, 32 K data set, and 3,000 or 6,000 scans per spectrum. Broad-band proton decoupling was applied throughout the collection. Postprocessing of the summed FID values included 1-Hz line broadening, Fourier transformation, and phase correction. Spectra were analyzed to determine the fraction of [2-13C]acetyl CoA entering the TCA cycle (Fc) and the ratio of anaplerotic flux to citrate synthase (y) (18). Although it has already been demonstrated that fractional enrichment of acetyl CoA (Fc) has no bearing on actual flux measurements (33, 34), the potential for pH effects needed to be assessed. In vitro 13C NMR spectra also allowed the end-point fractional enrichment of glutamate to be determined as described elsewhere (13).Kinetic Model and Analysis
The VTCA and interconversion rate (F1) between cytosolic glutamate and mitochondrial
-ketoglutarate were determined
by fitting 13C NMR data to a
kinetic model of metabolic activity. We present only a brief account of
the model here, whereas details are extensively reported elsewhere (33,
34).
Hearts are provided
[2-13C]acetate, which
contributes to the formation of acetyl CoA enriched at the C2 position
for entry into the TCA cycle. As shown in Fig.
1, this places the label at C4 of
-ketoglutarate.
-Ketoglutarate can be transaminated to form glutamate where the label is incorporated into the C4. The bulk of the
13C NMR-observed glutamate pool is
cytosolic (9), and the rate of the exchange has been shown to be
largely determined by the physical transport of
-ketoglutarate
across the mitochondrial membrane (34).
-Ketoglutarate could also be
oxidized by the dehydrogenase. Oxidation of
-ketoglutarate shifts
the label to C2 or C3 of the symmetric succinate molecule. As the
carbon label is recycled within the pathway and reenters the first span
of the cycle, the labeled carbon will label either C2 or C3 of
-ketoglutarate and glutamate.
|
Kinetic equations describing the presteady-state labeling of glutamate
and other key metabolic pools were derived by the principle of mass
conservation. This kinetic model is composed of nine differential equations defining the flux through each compartment and includes considerations of anaplerotic flux (33, 34). Metabolic pool sizes were
also required as input parameters. The concentrations of glutamate,
aspartate, citrate, and
-ketoglutarate were determined by enzymatic
assays. The concentration of metabolite pools known to be too small to
influence the flux measurements, such as malate and oxaloacetate, was
taken from the literature values obtained from hearts perfused under
similar substrate conditions: 0.60 mM malate and 0.04 mM oxaloacetate
(23, 28, 33).
VTCA and the
F1 between
cytosolic glutamate and mitochondrial
-ketoglutarate were determined
by nonlinear least-square fitting of the model to
13C NMR data of glutamate C2 and
C4 enrichment.
Isolated Mitochondria Experiments
Heart mitochondria were prepared from Dutch Belted rabbits according to the method of Chance and Hagihara (2) with few modifications. The animals were of the same age and size as for parallel NMR experiments on intact rabbit hearts. The initial fine mince of heart tissue was suspended in isolation medium consisting of 225 mM sucrose, 75 mM mannitol, 5 mM 3-(N-morpholino)propanesulfonic acid (pH 7.0), 0.1 mM EDTA, and 0.5 mg/1 ml of the proteinase nagarse (Sigma protease P4789). The tissue was rapidly dispersed with a Tekmar tissumizer set at low speed. The homogenate was then diluted 10-fold with isolation medium without nagarse. Mitochondria were separated from the homogenate by differential centrifugation omitting nagarse in subsequent washes (2). The isolated mitochondria had respiratory control ratios ranging from 7.0 to 10.0.Subsequent experiments with the mitochondria were carried out in
incubation media consisting of 120 mM KCl, 30 mM
3-(N-morpholino)propanesulfonic acid, 20 mM
KH2PO4,
5 mM NaCl, 2 mM MgCl2, 10 U/ml
hexokinase, and 20 mM glucose. Phosphate concentration in the media was
high because it was consumed at a rate of 2.5 µmol · ml
1 · min
1
over 4 min. However, because the dicarboxylate carrier for the exchange
of malate and inorganic phosphate is virtually absent in heart
mitochondria, the phosphate concentration of the buffer had no effect
on the activity of the
-ketoglutarate-malate exchanger (25). The pH
was adjusted to pH 7.2 (medium A) or
pH 6.8 (medium B), and experiments
were performed at 37°C.
The relative affinity of
-KGDH for the substrate
-ketoglutarate
was determined by following the rate of
-ketoglutarate oxidation. To
measure O2 consumption, 0.5 mg
mitochondrial protein was added to a stirred, temperature-equilibrated,
closed glass chamber fitted with a Clark electrode. Decreases of
O2 in the chamber were measured
polarographically. A double-reciprocal plot of oxygen consumption
versus initial
-ketoglutarate concentration was prepared. Oxygen
utilization was measured at six concentrations of
-ketoglutarate
ranging from 0.02 to 1.0 mM, and the apparent Km was determined
from the
-ketoglutarate concentration that produced one-half the
maximum oxygen consumption.
Other experiments were designed to measure individual reactions
involved in the metabolism of
-ketoglutarate. In these experiments mitochondria were incubated under one of the following four conditions for media at pH 7.2 or pH 6.8: condition
IA, 2.5 mM
[2,3-3H]glutamate, 2.5 mM [2-14C]pyruvate,
0.2 mM
-ketoglutarate, and 5 mM malate (pH 7.2); condition IB, same as
condition IA but adjusted to pH 6.8;
condition IIA, 2.5 mM
[2,3-3H]glutamate, 2.5 mM pyruvate, 0.2
-[U-14C]ketoglutarate,
and 5 mM malate (pH 7.2); or condition
IIB, same as condition
IIA but adjusted to pH 6.8. This allowed us to track the fate of
-ketoglutarate generated by isocitrate dehydrogenase (from [14C]pyruvate)
or by aspartate aminotransferase (from
[2,3-3H]glutamate) or
by transport across the mitochondrial membrane (from medium
-[U-14C]ketoglutarate
under similar incubation conditions with differing pH). Products of the
3H- and
14C-labeled substrates were
separated by ion exchange chromatography using Dowex 1 chloride columns
(17) and quantified by double-label counting in a liquid scintillation
counter. The design, rationale, and procedures for calculating fluxes
from these labeled substrates have been described previously in a study
of effects of Ca2+ and
H+ on
-ketoglutarate metabolism
in liver and kidney mitochondria (26).
Statistical Analysis
Data set comparisons were performed with Student's unpaired, two-tailed t-test. Differences in mean values were considered statistically significant at a probability level of <5% (P < 0.05). For analysis of paired transaminase enzymes from the same hearts at two different pH values, the paired t-test was applied.| |
RESULTS |
|---|
|
|
|---|
Studies in Isolated Mitochondria
pH effects on
-ketoglutarate metabolism and
efflux. The relative affinity of
-KGDH for the
substrate
-ketoglutarate as assessed by
Km was determined
at normal (pH 7.2) and low pH (pH 6.8) in isolated mitochondria by
following the rate of
-ketoglutarate oxidation. At an incubation
medium pH of 7.2, Km was 0.23 ± 0.06 mM, and at pH 6.8, Km was 0.10 ± 0.03 mM. The reduction in
Km indicates that
the affinity of
-KGDH for the substrate
-ketoglutarate increases
with a drop in pH. The decrease in the
Km of
-KGDH with increasing proton concentration has been reported previously for
intact mitochondria from kidney (26) and is now here confirmed in
intact cardiac mitochondria.
Subsequent experiments with isolated mitochondria were designed to find
out whether the increase in the affinity of
-KGDH for its substrate,
-ketoglutarate, significantly changes the ratio between the amount
of
-ketoglutarate that proceeds around the citric acid cycle
compared with the amount that effluxes from the mitochondria. To
establish the pH-dependent reduction in the Km of
-KGDH for heart mitochondria and
to measure the influence of altered
-ketoglutarate
oxidation on
-ketoglutarate efflux rates, we incubated
isolated rabbit heart mitochondria in the standard incubation
media plus 2.5 mM
[2-14C]pyruvate, 0.2 mM
-ketoglutarate, 2.5 mM
[2,3-3H]glutamate, 5 mM malate, 1 mM ADP, 20 mM glucose, and 10 U of hexokinase. The
hexokinase trap kept ADP high and respiration maximal. High malate
concentration trapped 14C cycling
around the citric acid cycle and ensured that no
14CO2
was generated from pyruvate. From data shown in Table
1, the amount of
[14C]glutamate formed
from [14C]pyruvate in
4 min demonstrates that at both normal and low pH, a factor of seven to
nine times more carbon from pyruvate leaves the mitochondria as
-[14C]ketoglutarate
than leaves as
[14C]glutamate.
|
From the condensation reaction catalyzed by citrate synthase, the
14C from pyruvate labels citrate,
isocitrate, and then
-ketoglutarate. At this point, the
radiolabel can enter one of three pathways, which were quantified by
chromatographic separation of the
14C-labeled metabolites. One
pathway involves transport of the
-ketoglutarate out of the
mitochondria through the
-ketoglutarate-malate exchange transporter. Without any added malate in the media to
enable this transport, no
-ketoglutarate will accumulate in the
suspension. A second pathway for the
-[14C]ketoglutarate
is oxidation to form succinate and malate. A third pathway is the
transamination inside the mitochondria via the mitochondrial GOT enzyme
to form
[14C]glutamate, a
small portion of which can leave the mitochondria via the slow
glutamate-hydroxyl carrier. In detecting these labeled metabolites in
the mitochondrial suspension, it is the metabolites that are in the
media and not inside the mitochondria that are measured, because the
intramitochondrial volume in the suspension is only 0.1% of the total
volume. As shown in Table 1, the amount of
[14C]glutamate formed
from [14C]pyruvate in
the mitochondria and released into the media was very small relative to
the amount of
-[14C]ketoglutarate
that accumulated in the suspension media. Thus any glutamate formed in
the mitochondria is only a small fraction of that which would be
detected in the cytosol of the intact hearts as opposed to the larger
pool of glutamate produced in the cytosol from
-ketoglutarate.
The products of
-KGDH were also monitored in similar experiments,
and the results are shown in Table 2. As
described above in the MATERIALS AND
METHODS, the incubation conditions differed with
respect to pH (either 6.8 or 7.2) and with respect to whether pyruvate
or
-ketoglutarate was labeled with 14C. All
three substrates (pyruvate, glutamate, and
-ketoglutarate) contribute to the flux through
-KGDH, and flux from each
was determined by measuring the amount of
14C and
3H in the
-KGDH products
succinate and malate. These constitute the major end products, since
fumarate and succinyl CoA could not be detected in these experiments
and since malate blocked further cycling. Also shown in Table 2 is the
rate of efflux of
-ketoglutarate generated by each substrate
compared with its rate of oxidation in the citric acid cycle by
-KGDH. The data indicate that lowering the
Km of
-KGDH
increases the percentage of
-ketoglutarate that is oxidized without
first entering the external medium, where in intact cells it
would be immediately converted to glutamate. Generation
of matrix
-ketoglutarate from glutamate was lower
than generation of
-ketoglutarate from pyruvate or from transport of
medium
-ketoglutarate into the matrix. When total flux from all
substrates through
-KGDH is compared with total
-ketoglutarate
efflux, the decrease in pH from 7.2 to 6.8 changes the
oxidation-to-efflux ratio from 1.02 to 1.92.
|
Isolated Heart Studies
Cardiac performance. Contractile function, intracellular pH, and oxygen consumption of isolated perfused hearts were all monitored. The control group displayed a mean workload of 17,100 ± 4,100 mmHg · beats · min
1,
intracellular pH 7.05, and
M
O2 19.4 ± 3.7 µmol · min
1 · g
1.
In the second group, reducing buffer pH to 6.6 resulted in a 30 ± 10% decline in RPP before augmentation with
Ca2+. Increasing
Ca2+ to 3.0 ± 1.0 mM elevated
RPP to control values (18,200 ± 5,600 mmHg · beats · min
1)
and M
O2 (24.0 ± 4.1 µmol · min
1 · g
1).
At this performance level, intracellular pH was 6.89 ± 0.04. Bioenergetic state was similar in both groups, as revealed by 31P NMR spectra.
Phosphocreatine-to-ATP ratios in both groups were control = 2.00 ± 0.52 and low pH group = 2.01 ± 0.37.
Flux measurements from intact hearts.
Representative proton-decoupled
13C spectra (time-enrichment
curves) of an isolated heart perfused with buffer pH adjusted to 6.6 and increased CaCl2 content and a
heart perfused under control conditions are shown in Fig.
2, A and
B, respectively. Control spectra are
similar to data previously presented (13, 14, 35). The signal
intensities arising from the glutamate C2 and C4 resonances were curve
fit to a Lorentzian line shape and plotted as a function of time.
Figure 3 shows this time course of
glutamate enrichment. These curves were fit to a single exponential,
and time constants were evaluated for the rise of each curve. The time
constants for the glutamate C4 and C2 of the control group were 9.4 and
16.5 min, respectively. For hearts perfused with buffer pH 6.6 and
increased CaCl2 content, glutamate
C4 and C2 enrichment time constants were 9.4 and 11.8 min,
respectively. These time constants are not a direct index of
VTCA, because
labeling of the glutamate is dependent on both the cycle flux and the
exchange of label between
-ketoglutarate and glutamate pools (34).
It should be noted, however, that the time constant for the C4 for
either group are similar, whereas the C2 time constants reveal a slower
enrichment rate in controls.
|
|
The results of kinetic analysis of the enrichment of glutamate provided
VTCA and the
F1 between
mitochondria
-ketoglutarate and cytosolic glutamate pools (33, 34).
The experimental perturbations and findings are summarized in Fig.
4.
VTCA was similar
in control hearts and in hearts with the reduced
Km of
-KGDH:
control group = 10.0 ± 0.2 µmol · min
1 · g
1;
low Km group = 10.1 ± 0.4 µmol · min
1 · g
1.
However, the F1
values of interconversion between
-ketoglutarate and glutamate,
which represent
-ketoglutarate efflux, were significantly reduced
with the reduction in the
Km of
-KGDH.
Control values for
F1 were 9.3 ± 0.6 µmol · min
1 · g
1
versus 2.8 ± 0.4 µmol · min
1 · g
1
at the low Km
(P < 0.05). These results indicate
that mitochondrial
-ketoglutarate exchange with cytosolic glutamate
is significantly reduced when the affinity of
-KGDH for
-ketoglutarate is increased. This result of reduced
F1 is attributed
to the Km change
in the dehydrogenases, because GOT is not sufficiently affected by pH changes over physiological range, as discussed below and elsewhere (5),
and the transporter is also insensitive to pH (22).
|
Metabolite content and in vitro
measurements. Steady-state metabolite contents are
listed in Table 3. Control values are in
agreement with those previously reported (15, 34). Citrate,
-ketoglutarate, and aspartate levels were not statistically
different between experimental groups. However, total glutamate content was 38% reduced in the hearts perfused at low pH and increased CaCl2. As shown in previous
studies (15, 34) and confirmed in Table 1, the cytosolic GOT enzyme is
the critical isoform of the transaminase that accounts for the observed
exchange of
-[13C]ketoglutarate
with the NMR-detected glutamate pool in the cytosol. Despite published
data showing only a very shallow dependence on pH across a wider range
from 6.0 to 8.0 (5), in our experiments the kinetic values for the
cytosolic GOT in both groups were actually reduced slightly by 24%
from a mean of 0.46 ± 0.07 µmol · min
1 · mg
total heart protein
1 at pH
7.2 (n = 6) to 0.35 ± 0.08 µmol · min
1 · mg
total heart protein
1 at pH
6.8 (n = 6)
(P < 0.05). From the
double-displacement reaction kinetics, this small but significant drop
in the activity of the cytosolic GOT corresponded to calculated flux
rates of 105 µmol · min
1 · g
dry wt
1 at pH 7.2 and 80 µmol · min
1 · g
dry wt
1 at pH 6.8 (15). The
slightly reduced GOT flux clearly remained too fast, by 29-fold in
comparison with
F1, to account
for the 70% reduction of
F1 at low pH.
These data are consistent with our previous observations that flux
through GOT is much too fast to account for the observed values of
interconversion between
-ketoglutarate and glutamate (15, 34).
|
In addition, high-resolution in vitro 13C NMR spectra of tissue extracts revealed that substrate utilization under these conditions was not affected by the percentage of acetyl groups entering the TCA cycle at citrate synthase that are enriched with 13C. The percentage of total acetyl CoA derived from exogenous 13C-enriched acetate was 92% in controls and 90% at low pH. The values were not different between groups, and moreover, this value does not affect the measurements of flux through the TCA cycle (33, 34). The relative contribution of anaplerotic flux into the TCA cycle versus that at citrate synthase was not different in either group (only ranging from 4 to 8%) and did not contribute to the differences observed in the flux measurements from intact hearts.
Comparison of
-ketoglutarate oxidation and efflux
in the two preparations. Corresponding values for
-ketoglutarate oxidation and efflux are catalogued in Table
4. Values for
F1 from intact hearts are shown as measurements of
-ketoglutarate efflux rates, because
-ketoglutarate influx-efflux across the mitochondrial membrane is known to predominate the rate contributions to
F1 (34). The
relative changes in the ratio of
-ketoglutarate efflux to oxidation
are consistent with a change in the
Km of
-KGDH in
the intact heart, as was confirmed for the isolated mitochondria.
|
| |
DISCUSSION |
|---|
|
|
|---|
Early work by Randle et al. (23) suggested that the TCA cycle operated
along two spans: acetyl CoA to
-ketoglutarate controlled by citrate
synthase, and
-ketoglutarate to oxaloacetate controlled by
-KGDH.
This scheme permits a redistribution of carbons between cycle
intermediates in the mitochondria during transition states of heart
workload. Thus
-KGDH balances flux through the two spans of the TCA
cycle. In addition,
-ketoglutarate is a common intermediate among
different pathways within the mitochondria and cytosol. Thus
competition for
-ketoglutarate between further oxidation in the TCA
cycle and efflux to the cytosol is partly regulated by
-KGDH. This
adjustment of cytosolic and mitochondrial
-ketoglutarate levels by
-KGDH is an important factor in coordinating flux with the
-ketoglutarate-malate transporter.
In the present study, the effects of altering the enzyme-substrate
affinity of a rate-limiting dehydrogenase enzyme of the TCA cycle on
metabolite exchange across the mitochondrial membrane were studied in
both intact hearts and isolated mitochondria. In experiments on intact
perfused hearts, metabolic rates were determined by fitting a kinetic
model of isotope enrichment to the dynamic
13C spectra acquired from hearts.
We have already demonstrated in a previous study that the measured
activity of the glutamate oxaloacetate transaminase is much too fast to
account for the observed rates of interconversion between
-[13C]ketoglutarate
from the mitochondria and glutamate in the cytosol (34), indicating
that
-ketoglutarate efflux from mitochondria is the rate-determining
step in the 13C labeling of the
large cytosolic glutamate pool. By combining additional
13C NMR experiments on intact
hearts with radioisotope studies of isolated mitochondria, we were able
to examine the balance between rates of
-ketoglutarate oxidation and
efflux in the current study.
The results from isolated hearts are consistent with those from the
isolated mitochondria to indicate that increasing the affinity of
-KGDH for the substrate
-ketoglutarate (i.e., a decrease in
Km) increased
-ketoglutarate oxidation relative to the rate of efflux from the
mitochondria for exchange with cytosolic glutamate. With the same
workload in both groups of hearts maintained, oxygen consumption and
VTCA were held
relatively constant despite altering the enzyme affinity with pH. The
influence of shifting the balance between
-ketoglutarate oxidation
and
-ketoglutarate efflux from the mitochondria was evident in the
reduced values for the
F1 between
-ketoglutarate and glutamate and the observed drop in glutamate.
These results demonstrate the link between mitochondrial and cytosolic
metabolites at this branch point between oxidation metabolism and
metabolic communication between the mitochondria and the cytosol.
Competition for substrate by the
-ketoglutarate transporter and
-KGDH exists by virtue of their apparent
Km values (11, 26, 27). Earlier work reported that the reversible, nonelectrogenic, pH-insensitive
-ketoglutarate-malate transporter of the
mitochondrial membrane has an apparent
Km of 1.5 mM for
-ketoglutarate on the matrix side of the carrier (3, 22, 24),
whereas the Km of
-KGDH for
-ketoglutarate was reported as 0.67 mM (11). This makes
both oxidation and efflux very sensitive to regulation by the
-ketoglutarate concentration in the mitochondrial matrix. The
transamination via GOT has been shown by others to be pH insensitive from pH 6 to 8 (5). In this study, we actually did find that the
cytosolic GOT isozyme showed a 24% reduction in activity at low pH,
but this relatively small drop in activity is not sufficient to produce
any measurable effect on the interconversion rate between
-ketoglutarate and glutamate
(F1) in the
heart. Instead, this drop in cytosolic GOT activity at pH 6.8 would
need to be at least 96.5% to affect the observed
F1. In addition,
the
-ketoglutarate transporter is already known to be pH independent
(8, 22). Therefore, the observed changes were due to the effect of pH
in reducing the
Km of the
-KGDH.
In this study, we report on the effect of pH on the
Km of
-KGDH in
isolated cardiac mitochondria. These values have been previously
reported for liver and kidney mitochondria (16, 26). The pH of the
bathing medium was reduced from 7.2 to 6.8, and the rate of
-ketoglutarate oxidation was followed as a function of oxygen
consumption. Under our conditions, the relative index Km of
-KGDH
affinity was 0.23 mM at pH 7.2, and at pH 6.8, Km reduced to
0.10 mM. In addition, the
Km of
-KGDH
for the substrate,
-ketoglutarate, has been shown to be largely
influenced by changes in intramitochondrial
Ca2+ (6, 19, 29). Wan et al. (29)
increased matrix free Ca2+ from 0 to 0.64 mM and reported the apparent
Km for
-ketoglutarate decreased from 2.5 to 0.6 mM. Thus increasing either
H+ or
Ca2+ content increased the
activity of
-KGDH, as reported by others (26, 29). In the present
study, 13C-NMR spectroscopy
provided a noninvasive means of studying such metabolic regulation in
the intact beating heart.
The analogous experiment to alter the
Km of
-KGDH
for
-ketoglutarate was performed in the intact functioning heart.
Energy demand and oxygen consumption were held constant by careful
regulation of buffer pH and CaCl2
content. Decreasing buffer pH resulted in an initial 30 ± 10%
reduction in heart RPP. This is consistent with results previously
reported for the isolated perfused heart (32). The reduction may be due
to the influence of H+ on
contractile processes that occur after the interaction between Ca2+ and troponin (4). At the low
buffer pH 6.6, 31P NMR spectra
revealed an intracellular pH of 6.89. Increasing CaCl2 content of the buffer
returned the RPP, energy demand, and M
O2 to normalized values. The
increase in intracellular Ca2+ and
H+ has been shown to increase both
intramitochondrial Ca2+ and
H+ content (7, 29). In the
isolated, perfused rabbit heart experiment, the affinity of
-KGDH
for
-KG was altered by changing intracellular pH and
Ca2+ content without changing net
flux through the enzyme reaction.
Kinetic analysis of dynamic 13C
NMR data provided
VTCA and
F1 between
-ketoglutarate and glutamate. Figure 4 shows the results with
reference to the TCA cycle and transport pathways first illustrated in
Fig. 1. Several important points can be inferred from these data.
First, VTCA was
driven by the energetic demands of the matched workloads in both
groups of hearts (control group, RPP = 17,000 ± 4,100 mmHg · beats · min
1;
reduced Km group,
RPP = 18,200 ± 5,600 mmHg · beats · min
1).
Therefore, the perturbations of pH and
Ca2+ were observed at fixed
TCA cycle rates (control group,
VTCA = 10.0 ± 0.2 µmol · min
1 · g
1;
reduced Km
group, VTCA = 10.1 ± 0.4 µmol · min
1 · g
1).
Second, the reduction in the interconversion rate between
-ketoglutarate and glutamate (control group,
F1 = 9.3 ± 0.6 µmol · min
1 · g
1;
reduced Km group,
F1 = 2.8 ± 0.4 µmol · min
1 · g
1),
along with the observed drop in cytosolic glutamate (control group,
[Glu] = 29.1 ± 3.0 mmol/g; reduced
Km group,
[Glu] = 17.7 ± 3.0 mmol/g), suggests that the
dehydrogenase was able to out compete the membrane transporter for
-ketoglutarate. This would be possible if the
affinity of the dehydrogenase for
-ketoglutarate had increased
(i.e., a decrease in
Km) with the
drop in pH and increase in Ca2+.
At a constant
VTCA, this
probably slowed the rate of
-ketoglutarate efflux for
interconversion with glutamate in the cytosol. The observed reduction
in the total glutamate pool in response to lowered pH is consistent
with this hypothesis.
The result of the relative increase in the ratio
-ketoglutarate
oxidation to efflux from the mitochondria followed by conversion to
cytosolic glutamate is that labeled
-ketoglutarate is recycled to
succinate at a rate faster than that at which it is converted to
glutamate. This change accelerates the mixing of the label from the C4
to the C2 position within the TCA cycle relative to the exchange of
-ketoglutarate with the glutamate pool. This condition, along with
the reduction in glutamate pool size, caused the time difference
between labeling at C4 and C2 of glutamate to become reduced without
changes in net
VTCA. This
perturbation resulted in little if any difference in the rate of
appearance of 13C at the C4
position of glutamate (time constant = 9.4 min), whereas labeling at
the C2 position occurred at an increased rate that was associated with
a reduction in the time constant from 16.5 to 11.8 min. The results of
our kinetics analysis also accounted for this perturbation by
demonstrating no change in
VTCA with the
reduction in F1.
Although experiments with isolated mitochondria were intended to
confirm the effectiveness of the protocol to manipulate
Km (26), it is of
interest that the pH response in the ratios of
-ketoglutarate
oxidation to efflux were closely matched between intact hearts and
isolated mitochondria metabolizing labeled glutamate. In these
instances (see Table 2), oxidation-to-efflux ratios at normal pH were
1.28 in isolated mitochondria and 1.08 in intact hearts, and
oxidation-to-efflux ratios at low pH were 3.76 in isolated mitochondria
versus 3.57 in intact hearts. In the isolated mitochondria, the ratio
of
-ketoglutarate oxidation to efflux varied somewhat depending on
the source of the
-ketoglutarate and on pH. However, the pH effect
was largest when
-ketoglutarate was generated by aspartate
aminotransferase via
[2,3-3H]glutamate.
This is probably due to compartmentation within the mitochondria. As
noted in the results, the production of matrix
-ketoglutarate from
glutamate in isolated mitochondria was lower than the production of
-ketoglutarate from pyruvate or from the
-ketoglutarate entering
from the medium. The aminotransferase, therefore, may have had access
to a particular pool of
-KGDH that was not available to the other
substrates and was therefore less saturated than pools of
-KGDH near
the
-ketoglutarate translocase or near isocitrate dehydrogenase.
Thus the effect of the pH change may have been largest on this least
saturated pool of
-KGDH, as may be expected for the intact
functioning heart, which showed strikingly similar ratios to that
observed in mitochondria metabolizing labeled glutamate. In any event,
it seems likely that the substrate-related differences in the effect of
pH on the oxidation-to-efflux ratio was due to lack of mixing and slow
diffusion in the mitochondrial matrix. In each instance, independent of
the source of the
-ketoglutarate generated in the matrix, a decrease
in pH substantially changed the percentage of the
-ketoglutarate,
which continues on in the citric acid cycle without exciting the
mitochondria.
In conclusion, sequential 13C NMR
spectra were obtained from intact hearts under conditions of normal and
altered
-KGDH kinetics during perfusion with
[2-13C]acetate.
Dynamic 13C NMR analysis revealed
the balance between mitochondria TCA cycle rates and metabolite
exchange between the mitochondria and cytosol. The data indicate that
elevated H+ and
Ca2+ content increased
-ketoglutarate oxidation and reduced
-ketoglutarate efflux from
the mitochondria and isotope exchange with cytosolic glutamate. These
results indicate that 13C NMR is
sensitive to changes in kinetic parameters of the TCA cycle
dehydrogenases within the mitochondria of intact hearts as confirmed by
our parallel experiments in mitochondria.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants RO1 HL-49244 (to E. D. Lewandowski), RO1 HL-56178 (to E. D. Lewandowski), and P01 HL-18708-21 (to K. F. LaNoue) and was performed during the tenure of an Established Investigator Award from the American Heart Association to E. D. Lewandowski. The findings of this study have been presented, in part, in abstract form at the 69th Scientific Sessions of the American Heart Association.
| |
FOOTNOTES |
|---|
Address for reprint requests: E. D. Lewandowski, NMR Center, Massachusetts General Hospital, Bldg. 149, 13th St., Charlestown, MA 02129.
Received 7 July 1997; accepted in final form 15 October 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bergmeyer, J. U.
Methods of Enzymatic Analysis. New York: Academic, 1974.
2.
Chance, B. C.,
and
B. Hagihara.
Initiation of succinate oxidation in aged pigeon heart mitochondria.
Biochem. Biophys. Res. Commun.
3:
1-5,
1960.
3.
DeHaan, E. J.,
J. M. Tager,
and
E. C. Slater.
Factors affecting the pathway of glutamate oxidation in rat liver mitochondria.
Biochim. Biophys. Acta
131:
1-13,
1967.
4.
Fabiato, A.,
and
F. Fabiato.
Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscles.
J. Physiol. (Lond.)
276:
233-255,
1978
5.
Fleisher, G. A,
C. S. Potter,
and
K. G. Wakim.
Separation of two glutamate oxalacetate transaminases by paper electrophoresis.
Proc. Soc. Exp. Biol. Med.
103:
229-331,
1960.
6.
Hansford, R. G.
Dehydrogenase activation by Ca2+ in cells and tissues.
J. Bioenerg. Biomembr.
23:
823-854,
1991[Medline].
7.
Hutson, S. M.,
G. D. Willis,
D. A. Berkich,
K. F. LaNoue,
and
R. W. Briggs.
A 31P NMR study of mitochondrial inorganic phosphate visibility: effects of Ca++, Mn++, and pH gradients.
Biochem. J.
31:
1322-1330,
1992.
8.
Indiveri, C.,
F. Palmieri,
F. Bisaccia,
and
R. Kramer.
Kinetics of the reconstituted oxoglutarate carrier from bovine heart mitochondria.
Biochim. Biophys. Acta
890:
310-318,
1987[Medline].
9.
LaNoue, K. F.,
W. J. Nicklas,
and
J. R. Williamson.
Control of citric acid cycle activity in rat heart mitochondria.
J. Biol. Chem.
245:
102-111,
1970
10.
LaNoue, K. F.,
and
A. C. Schoolwerth.
Metabolite transport in mitochondria.
Annu. Rev. Biochem.
48:
871-922,
1979[Medline].
11.
LaNoue, K. F.,
E. I. Walajtys,
and
J. R. Williamson.
Regulation of glutamate metabolism and interactions with the citric acid cycle in rat heart mitochondria.
J. Biol. Chem.
248:
7171-7183,
1973
12.
LaNoue, K. F.,
and
J. R. Williamson.
Interrelationships between malate-aspartate shuttle and citric acid cycle in rat heart mitochondria.
Metabolism
20:
119-140,
1971[Medline].
13.
Lewandowski, E. D.
Nuclear magnetic resonance evaluation of metabolic and respiratory support of work load in intact rabbit hearts.
Circ. Res.
70:
576-582,
1992
14.
Lewandowski, E. D.,
and
C. Hulbert.
Dynamic changes in 13C NMR spectra of intact hearts under conditions of varied metabolic enrichment.
Magn. Reson. Med.
19:
186-190,
1991[Medline].
15.
Lewandowski, E. D.,
X. Yu,
K. F. LaNoue,
L. T. White,
C. Doumen,
and
J. M. O'Donnell.
Altered metabolite exchange between subcellular compartments in intact postischemic rabbit hearts.
Circ. Res.
81:
165-175,
1997
16.
Lowry, M.,
and
B. D. Ross.
Activation of oxoglutarate dehydrogenase in the kidney in response to acute acidosis.
Biochem. J.
190:
771-780,
1980[Medline].
17.
Lynch, C. J.,
H. Fox,
S. A. Hazen,
B. A. Stanley,
S. J. Dodgson,
and
K. F. LaNoue.
The role of hepatic carbonic anhydrase in de novo lipogenesis.
Biochem. J.
310:
197-202,
1995.
18.
Malloy, C. R.,
A. D. Sherry,
and
F. M. H. Jeffrey.
Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy.
J. Biol. Chem.
263:
6964-6971,
1988
19.
McCormack, J. G.,
A. P. Halestrap,
and
R. M. Denton.
Role of calcium ions in regulation of mammalian intramitochondrial metabolism.
Physiol. Rev.
70:
391-425,
1990
20.
Moon, R. B.,
and
J. H. Richards.
Determination of intracellular pH by 31P magnetic resonance.
J. Biol. Chem.
248:
7276-7278,
1973
21.
Neely, J.,
H. Liebermeister,
E. Battersby,
and
H. Morgan.
Effect of pressure development on oxygen consumption by isolated rat heart.
Am. J. Physiol.
212:
804-814,
1967.
22.
Papa, S.,
N. E. Lofrumento,
E. Quagliariello,
A. J. Meijer,
and
J. M. Tager.
Coupling mechanisms in anionic substrate transport across the inner membrane of rat-liver mitochondria.
J. Bioenerg.
1:
287-307,
1970.
23.
Randle, P. J,
P. J. England,
and
R. M. Denton.
Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart.
Biochem. J.
117:
677-695,
1970[Medline].
24.
Sluse, F. E.,
G. Goffart,
and
C. Liebecq.
Mechanism of the exchanges catalysed by the oxoglutarate translocator of rat-heart mitochondria. Kinetics of the external-product inhibition.
Eur. J. Biochem.
32:
283-291,
1973[Medline].
25.
Sluse, F. E.,
A. J. Meijer,
and
J. M. Tager.
Anion translocation in rat heart mitochondria.
FEBS Lett.
18:
149-153,
1971[Medline].
26.
Smith, B. C.,
L. A. Clotfelter,
J. U. Cheung,
and
K. F. LaNoue.
Differences in 2-oxoglutarate dehydrogenase regulation in liver and kidney.
Biochem. J.
284:
819-826,
1992.
27.
Strzelecki, T.,
D. Strzelecka,
C. D. Koch,
and
K. F. LaNoue.
Sites of action of glucagon and other Ca2+ mobilizing hormones on the malate aspartate cycle.
Arch. Biochem. Biophys.
264:
310-320,
1988[Medline].
28.
Taegtmeyer, H.
On the inability of ketone bodies to serve as the only energy providing substrate for rat heart at physiological work load.
Basic Res. Cardiol.
78:
435-450,
1983[Medline].
29.
Wan, B.,
K. F. LaNoue,
J. Y. Cheung,
and
R. C. Scaduto.
Regulation of citric acid cycle by calcium.
J. Biol. Chem.
264:
13430-13439,
1989
30.
Williamson, J. R.,
and
B. E. Corkey.
Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods.
In: Methods in Enzymology, edited by J. M. Colowick. New York: Academic, 1969, p. 434-514.
31.
Williamson, J. R.,
B. Safer,
K. F. LaNoue,
C. M. Smith,
and
E. Walajtys.
Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol. Proc. Soc. Exp. Biol. Symposium No. 27, edited by D. D. Davis. Oxford, UK: Cambridge Univ. Press, 1973, p. 241-281.
32.
Williamson, J. R.,
B. Safer,
T. Rich,
S. Schaffer,
and
K. Kobayashi.
Effects of acidosis on myocardial contractility and metabolism.
Acta Med. Scand. Suppl.
587:
95-111,
1975.
33.
Yu, X.,
N. M. Alpert,
and
E. D. Lewandowski.
Modeling enrichment kinetics from dynamic 13C NMR spectra: theoretical analysis and practical considerations.
Am. J. Physiol.
272 (Cell Physiol. 41):
C2037-C2048,
1997
34.
Yu, X.,
L. T. White,
C. Doumen,
L. A. Damico,
K. F. LaNoue,
N. M. Alpert,
and
E. D. Lewandowski.
Kinetic analysis of dynamic 13C NMR spectra: metabolic flux, regulation, and compartmentation in hearts.
Biophys. J.
69:
2090-2102,
1995
35.
Yu, X.,
L. T. White,
N. M. Alpert,
and
E. D. Lewandowski.
Subcellular metabolite transport and carbon isotope kinetics in the intramyocardial glutamate pool.
Biochemistry
35:
6963-6968,
1996[Medline].
This article has been cited by other articles:
![]() |
J. M. O'Donnell, A. Fields, X. Xu, S. A. K. Chowdhury, D. L. Geenen, and J. Bi Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2483 - H2494. [Abstract] [Full Text] [PDF] |
||||
![]() |